Effective January 20, 2017, Rule 64B13-18.002, F.A.C. adds Xiidra (Lifitegrast Ophthalmic Solution) 5% to the formulary and allows Florida Optometrists to prescribe the medication to their patients.
Xiidra Approved on January 20, 2017
![](https://floridasoptometry.gov/wp-content/themes/dohboards/img/divider.png)
Posted in Latest News on January 20, 2017.